LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Adhesives Research to Present Hydrophilic Adhesive Technologies

By LabMedica International staff writers
Posted on 03 Aug 2016
Print article
Image: Hydrophilic technologies for microfluidic devices (Photo courtesy of Adhesives Research).
Image: Hydrophilic technologies for microfluidic devices (Photo courtesy of Adhesives Research).
Adhesives Research (AR; Glen Rock, PA, USA), a leading developer and manufacturer of high-performance pressure-sensitive adhesives, tapes, specialty coatings, films, and laminates, will hold a presentation at AACC 2016 on the range of opportunities for hydrophilic adhesive technologies, which are expanding as demand for microfluidic biological tests increases. They will also be presenting a range of custom tailored products, from devices that detect infectious diseases to test kits that monitor diabetes and blood coagulation.

Hydrophilic adhesive technologies reduce the surface tension of fluids, such as water, urine, or blood to allow for rapid flow from the inlet area to a remote reagent site within in vitro diagnostic (IVD) and microfluidic devices. Available as pressure-sensitive adhesives (PSAs), heat-seals, and coatings, the technology is compatible with sensitive chemistries, demonstrates strong bonding to low-surface energy plastics, provides tailorable hydrophilic properties to regulate capillary fill time, and can be customized by modifying thickness, choice of substrate, and release liner.

“Hydrophilic technology continues to be used in a variety of medical devices, including blood glucose and blood coagulation point-of-care, in-house, and environmental test kits,” said Herb Hand, a senior scientist with over 24 years pioneering research on hydrophilic adhesives and coatings at AR, who will lead the discussion. “The future of hydrophilic tapes includes components in molecular diagnostic devices and devices for the discovery of infectious diseases.”

AR leverages core competencies in chemical synthesis formulation and coating technologies to provide a gamut of custom tailored products for diverse applications around the world in the construction, industrial, electronics, automotive, medical, and pharmaceutical industries. AR also operates manufacturing facilities in Ireland and Colombia; has sales and marketing offices in Great Britain, Singapore and China; and sales representation in Japan and Taiwan.

The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.

Related Links:
Adhesives Research
American Association for Clinical Chemistry
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAb Immunoassay
Chorus TRAb
New
Creatine Kinase-MB Assay
CK-MB Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.